Text Size

Tianjin Gestational Diabetes Prevention Program (TGDPP) (GDM)

This study is currently recruiting participants.
Verified March 2012 by Tianjin Women and Children's Health Center
Sponsor:
Information provided by (Responsible Party):
HunKun Liu, Tianjin Women and Children's Health Center
ClinicalTrials.gov Identifier:
NCT01554358
First received: December 13, 2011
Last updated: March 12, 2012
Last verified: March 2012
History of Changes
  Purpose

A total of 1,180 women diagnosed with Gestational Diabetes Mellitus (GDM) from 2005 to 2009 have and continues to be randomly assigned to either the intervention group or the control group. GDM women in the intervention group will have five consulting sessions with a dietician during the first year and two sessions during the second year. The intervention group are given detailed advice about how to achieve the six goals of the intervention. The primary aim will test whether lifestyle intervention can reduce incident Type 2 Diabetes (T2D) in women with prior GDM. The second aim will test gene-intervention interactions through fine-mapping established genes for glucose, IR, lipids, obesity and T2D in relation to metabolic traits for T2D in GDM women.


Condition Intervention
Gestational Diabetes Mellitus (GDM)
 Behavioral: Lifestyle intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Prevention
Official Title: Lifestyle and Genetic Factors on Diabetes Risk in Women With GDM After Delivery: Tianjin Gestational Diabetes Prevention Program (TGDPP)

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Tianjin Women and Children's Health Center:

Primary Outcome Measures:
  • incident type 2 diabetes [ Time Frame: during 2-year follow-up ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • approximately 40 SNPs [ Time Frame: during 2-year follow-up ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 1180
Study Start Date: August 2009
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Lifestyle counseling
The women in the intervention group will be given detailed advice about how to achieve the six evidence-based goals of the intervention,7-9 including: 1) reduction in 5-10% of initial body weight in women with body mass index (BMI) ≥24 kg/m2 through the reduction of at least 10% of total calories of their normal meals, 2) total fat intake <30% of energy consumed, 3) saturated fat intake <10% of energy consumed, 4) carbohydrate intake 55-65% of energy consumed, 5) fiber intake 20-30g per day, and 6) moderate or vigorous exercise for at least 30 min daily, seven days each week.
 Behavioral: Lifestyle intervention

The women in the intervention group will be given detailed advice about how to achieve the six evidence-based goals of the intervention,7-9 including: 1) reduction in 5-10% of initial body weight in women with body mass index (BMI) ≥24 kg/m2 through the reduction of at least 10% of total calories of their normal meals, 2) total fat intake <30% of energy consumed, 3) saturated fat intake <10% of energy consumed, 4) carbohydrate intake 55-65% of energy consumed, 5) fiber intake 20-30g per day, and 6) moderate or vigorous exercise for at least 30 min daily, seven days each week.

--------------------------------------------------------------------------------
No Intervention: Control
the subjects in the control group had been educated regarding general principles of healthy lifestyle that benefits T2D and obesity prevention, and also informed about the current evidence showing that the lifestyle intervention is effective in women at high risk for T2D during the "run-in" period.

  Eligibility

Ages Eligible for Study:   20 Years to 49 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Age 20-49 years
  2. Women diagnosed with GDM between 2005 and 2009.

Exclusion Criteria:

  1. Age < 20 and ≥ 50 years
  2. Newly diagnosed diabetes in the screening visit
  3. The presence of any chronic diseases that could seriously reduce their life expectancy or their ability to participate in the trial
  4. Unable or unwilling to give informed consent or communicate with study staff
  5. Currently pregnant, or planning to become pregnant in the next four years
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01554358

Contacts
Contact: Huikun Liu, PhD 86 2258297935 huikun_liu@sina.com

Locations
China
Tianjin Women's and Children's Health Center Recruiting
Tianjin, China, 30070
Contact: Huikun Liu, PhD         huikun_liu@sina.com    
Principal Investigator: Huiguang Tian, PhD            
Principal Investigator: Gang Hu, PhD            
Sponsors and Collaborators
HunKun Liu
  More Information

No publications provided

Responsible Party: HunKun Liu, Project co-investigator, Tianjin Women and Children's Health Center
ClinicalTrials.gov Identifier: NCT01554358     History of Changes
Other Study ID Numbers: TWCHC09-01
Study First Received: December 13, 2011
Last Updated: March 12, 2012
Health Authority: China: Ministry of Health

Keywords provided by Tianjin Women and Children's Health Center:
Gestational diabetes mellitus
Lifestyle intervention

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes, Gestational
Glucose Metabolism Disorders
 Metabolic Diseases
Endocrine System Diseases
Pregnancy Complications

ClinicalTrials.gov processed this record on May 23, 2013